echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Endocrine System > BMJ Sub-Journal: The long-term incidence trend of type 1 and type 2 diabetes and the impact of population aging on mortality in China from 1990 to 2019

    BMJ Sub-Journal: The long-term incidence trend of type 1 and type 2 diabetes and the impact of population aging on mortality in China from 1990 to 2019

    • Last Update: 2021-11-12
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    According to the latest national survey in China, the prevalence of diabetes rose from 0.


    According to the latest national survey in China, the prevalence of diabetes rose from 0.


    Diabetes and population aging have become public health issues of global concern


    Diabetes and population aging have become public health issues of global concern


    Based on this, this study extracted the incidence and mortality of T1DM and T2DM from 1990 to 2019 from the Global Burden of Disease Study (GBD) 2019 database


    Changes in the number of T1DM-related and T2DM-related deaths related to population aging, population growth, and mortality changes from 1990 to 2019

    Changes in the number of T1DM-related and T2DM-related deaths related to population aging, population growth, and mortality changes from 1990 to 2019 Changes in the number of deaths Changes in the number of T1DM-related and T2DM-related deaths related to population aging, population growth, and changes in mortality between 1990 and 2019

    The results of the study show that from 1990 to 2019, the age-standardized incidence rate of T1DM (ASIR) increased by 2.


    The results of the study showed that from 1990 to 2019, the age-standardized incidence rate (ASIR) of T1DM increased by 2.


    All in all, in T1DM and T2DM prevalence countries continues to rise, especially among young people


    References: References: LiY ,GuoC ,CaoY LiY Li GuoC Guo CaoY Cao BMJ Open Diabetes Research and Care  2021; 9: e002529.
      doi:  10.
    1136/bmjdrc-2021-002529 doi:  10.
    1136/bmjdrc- 2021-002529 doi:

    leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.